A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy Volunteers
Status:
Completed
Trial end date:
2021-03-11
Target enrollment:
Participant gender:
Summary
This study is randomized, single-blind, placebo-controlled Phase 1 study aimed to assess the
safety and efficacy, pharmacokinetics and pharmacodynamics of multiple doses of oral AZD4831
in healthy Japanese and Chinese volunteers